Driving ability under long-term treatment with transdermal fentanyl

Journal of Pain and Symptom Management

Volumn 25, Issue 1, 2003, Pages 38-47

  Sabatowski, Rainer ^a   Schwalen, Susanne ^b   Rettig, Klaus ^c   Herberg, Klaus W ^d   Kasper, Stephan M ^a   Radbruch, Lukas ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b JANSSEN CILAG GMBH   (Germany)

^c Bureau of Evaluation and Quality Assurance in Medicine   (Germany)

^d BioTech GmbH   (Germany)

Author keywords

Cognition; Driving ability; Non cancer pain; Psychomotor performance; Transdermal fentanyl

Indexed keywords

FENTANYL;

ADULT; AGED; ALERTNESS; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRIVING ABILITY; FEMALE; HUMAN; LONG TERM CARE; MALE; MOTOR COORDINATION; OUTCOMES RESEARCH; PAIN; PERFORMANCE; PSYCHOMOTOR ACTIVITY; VISUAL ORIENTATION;

ADULT; ANALGESICS, OPIOID; AUTOMOBILE DRIVING; COGNITION; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHOMOTOR PERFORMANCE;

EID: 0037253514     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(02)00539-0     Document Type: Article

References (49)

1. Portenoy R.K. Current pharmacotherapy of chronic pain. J Pain Symptom Manage. 19:2000;S16-S20.
2. Savage S.R. Opioid use in the management of chronic pain. Med Clin North Am. 83:1999;761-786.
3. Portenoy R.K. Tolerance to opioid analgesics. clinical aspects Cancer Surv. 21:1994;49-65.
4. Bruera E., Macmillan K., Hanson J., MacDonald R.N. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain. 39:1989;13-16.
5. de Stoutz N.D., Bruera E., Suarez-Almazor M. Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. 10:1995;378-384.
6. Banning A., Sjogren P. Cerebral effects of long-term oral opioids in cancer patients measured by continuous reaction time. Clin J Pain. 6:1990;91-95.
7. Sjogren P., Thomsen A.B., Olsen A.K. Impaired neuropsychological performance in chronic nonmalignant pain patients receiving long-term oral opioid therapy. J Pain Symptom Manage. 19:2000;100-108.
8. Vainio A., Ollila J., Matikainen E.et al. Driving ability in cancer patients receiving long-term morphine analgesia. Lancet. 346:1995;667-670.
9. Larsen B, Otto H, Dorscheid E, Larsen R. [Effects of long-term opioid therapy on psychomotor function in patients with cancer pain or non-malignant pain]. Anaesthesist 1999;48:613-624.
10. Hanks G.W., O'Neill W.M., Simpson P., Wesnes K. The cognitive and psychomotor effects of opioid analgesics. II. A randomized controlled trial of single doses of morphine, lorazepam and placebo in healthy subjects. Eur J Clin Pharmacol. 48:1995;455-460.
11. Galski T., Williams J.B., Ehle H.T. Effects of opioids on driving ability. J Pain Symptom Manage. 19:2000;200-208.
12. Schneider U., Bevilacqua C., Jacobs R.et al. Effects of fentanyl and low doses of alcohol on neuropsychological performance in healthy subjects. Neuropsychobiology. 39:1999;38-43.
13. Stevenson G.W., Pathria M.N., Lamping D.L.et al. Driving ability after intravenous fentanyl or diazepam. A controlled double-blind study. Invest Radiol. 21:1986;717-719.
14. Zacny J.P., Lichtor J.L., Zaragoza J.G., de Wit H. Subjective and behavioral responses to intravenous fentanyl in healthy volunteers. Psychopharmacology (Berl). 107:1992;319-326.
15. Thapar P., Zacny J.P., Thompson W., Apfelbaum J.L. Using alcohol as a standard to assess the degree of impairment induced by sedative and analgesic drugs used in ambulatory surgery. Anesthesiology. 82:1995;53-59.
16. Veselis R.A., Reinsel R.A., Feshchenko V.A.et al. Impaired memory and behavioral performance with fentanyl at low plasma concentrations. Anesth Analg. 79:1994;952-960.
17. Dellemijn P.L., van Duijn H., Vanneste J.A. Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage. 16:1998;220-229.
18. Donner B., Zenz M., Strumpf M., Raber M. Long-term treatment of cancer pain with transdermal fentanyl. J Pain Symptom Manage. 15:1998;168-175.
19. Nugent M., Davis C., Brooks D., Ahmedzai S. Long-term observations of patients receiving transdermal fentanyl after a randomized trial. J Pain Symptom Manage. 21:2001;385-391.
20. Radbruch L., Sabatowski R., Petzke F.et al. Transdermal fentanyl for the management of cancer pain - a survey of 1005 patients. Pall Med. 15:2001;309-321.
21. Herberg K. Untersuchung der Entwicklung der sicherheitsrelevanten Leistungsfähigkeit mit dem Lebensalter, 2 ed. 1998;TÜV Kraftfahrt GmbH - Institut für Verkehrssicherheit, Köln.
22. Herberg K.W. Entwicklung der sicherheitsrelevanten Leistungsfähigkeit mit dem Lebensalter. Euro J Ger. 2:2000;18-26.
23. Bundesregierung D. Verordnung über die Zulassung von Personen zum Strassenverkehr und zur Änderung strassenverkehrsrechtlicher Vorschriften. Bundesgesetzblatt. 55:1998;2214-2262.
24. International Council on Alcohol Drugs and Traffic Safety. Guidelines on experimental studies undertaken to determine a medicinal drug's effect on driving or skills related to driving. 1999, Available at: www.agnp.de .
25. Kroj G. Psychologisches Gutachten Kraftfahreignung. 1995;Psychologenverlag, Deutscher Bonn.
26. Schuhfried GmbH, ed. Cognitrone - Handbuch. 1994, Dr. Schuhfried GmbH: Mödling.
27. Schuhfried GmbH, ed. Wiener Determinationstest, Version 2.00. 1996, Dr. Schuhfried GmbH: Mödling.
28. Schuhfried GmbH, ed. Zweihand-Koordination, Version 4.00. 1995, Dr. Schuhfried GmbH: Mödling.
29. Schuhfried GmbH, ed. Vigilanz, Version 5.00. 1995, Dr. Schuhfried GmbH: Mödling.
30. Richter R, Hobi V. [The impairment of the ability to drive with blood alcohol concentrations of 0.5 per mille. A review of the literature]. Schweiz Med Wochenschr 1975;105:884-890.
31. Bartl G, Lager F, Domesle L. [Test performance with minimal alcoholic intoxication]. Blutalkohol 1996;33:1-16.
32. Herberg KW. [Antidepressives and traffic safety]. Fortschr Neurol Psychiatr 1994;1:24-28.
33. O'Brien P. Procedures for comparing samples with multiple endpoints. Biometrics. 40:1984;1079-1087.
34. Hemmelgarn B., Suissa S., Huang A.et al. Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA. 278:1997;27-31.
35. Soyka M, Dittert S, Gartenmeier A, Schafer M. [Driving fitness in therapy with antidepressive drugs]. Versicherungsmedizin 1998;50:59-66.
36. Lorenz J., Baumgärtner U., Zander A., Bromm B. Differenzierung von schmerz- und morphinbedingter Beeinträchtigung kognitiver Leistungen und subjektiver Befindlichkeit bei Knochenmarktransplantationspatienten. Schmerz. 10:1996;80-88.
37. Lorenz J., Beck H., Bromm B. Cognitive performance, mood and experimental pain before and during morphine-induced analgesia in patients with chronic non-malignant pain. Pain. 73:1997;369-375.
38. Zacny J.P., Lichtor J.L., Thapar P.et al. Comparing the subjective, psychomotor and physiological effects of intravenous butorphanol and morphine in healthy volunteers. J Pharmacol Exp Ther. 270:1994;579-588.
39. Zacny J.P., Conley K., Galinkin J. Comparing the subjective, psychomotor and physiological effects of intravenous buprenorphine and morphine in healthy volunteers. J Pharmacol Exp Ther. 282:1997;1187-1197.
40. Zacny J.P., Hill J.L., Black M.L., Sadeghi P. Comparing the subjective, psychomotor and physiological effects of intravenous pentazocine and morphine in normal volunteers. J Pharmacol Exp Ther. 286:1998;1197-1207.
41. Hill J.L., Zacny J.P. Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers. Psychopharmacology (Berl). 152:2000;31-39.
42. Walker D.J., Zacny J.P. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther. 289:1999;1454-1464.
43. Walker D.J., Zacny J.P. Subjective, psychomotor, and analgesic effects of oral codeine and morphine in healthy volunteers. Psychopharmacology (Berl). 140:1998;191-201.
44. Haythornthwaite J.A., Menefee L.A., Quatrano-Piacentini A.L., Pappagallo M. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage. 15:1998;185-194.
45. Strumpf M., Köhler A., Zenz M.et al. Opioide und Fahrtüchtigkeit. Schmerz. 11:1997;233-240.
46. Schulzeck S., Maier C., Rochholz G., Schütz H. Stellenwert des "Medikamenten-Screenings" in der Therapie chronischer Schmerzen. Schmerz. 13:1999;133-137.
47. Brown S.C., Glass J.M., Park D.C. The relationship of pain and depression to cognitive function in rheumatoid arthritis patients. Pain. 96:2002;279-284.
48. Emsbach M, Friedel B. [Traffic accidents of senior citizen car drivers]. Z Gerontol Geriatr 1999;32:318-325.
49. Willette R., Walsh J. Drugs, driving, and traffic safety. 1983;World Health Organization, Geneva.